According to a new report by Polaris Market Research, the global gene silencing market was valued at USD 9.93 billion in 2024 and is projected to reach USD 35.77 billion by 2034, expanding at a CAGR of 13.7% over the forecast period. Growth is underpinned by rising genetic disorders and chronic diseases, advancing RNA therapeutics and delivery systems, and accelerating R&D...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek